Detalhe da pesquisa
1.
The Case | Refractory anemia in a patient undergoing dialysis.
Kidney Int
; 105(1): 211-212, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38182293
2.
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group.
Cancers (Basel)
; 16(5)2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473382